NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Pharma Market Research Conference
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Top Pharmaceutical Experts All Coming to Groundbreaking Event in East Brunswick, New Jersey on September 17-18 - The Pharma CI Conference & Exhibition is the best and largest assembly of pharmaceutical competitive intelligence executives - PharmaCIConference.com
Top Pharmaceutical Experts All Coming to Groundbreaking Event in East Brunswick, New Jersey on September 17-18

 

NewswireToday - /newswire/ - New York, NY, United States, 2013/08/08 - The Pharma CI Conference & Exhibition is the best and largest assembly of pharmaceutical competitive intelligence executives - PharmaCIConference.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Next month, global leaders in pharmaceuticals, healthcare, biotechnology, and medical devices will converge at the Pharma CI Conference & Exhibition on September 17-18, 2013 in East Brunswick, New Jersey, USA.

This event offers the very best in pharmaceutical competitive intelligence. Conference participants will attain real-world knowledge from the talented speaking faculty of 75+ senior level speakers (45+ biopharma speakers & 25+ new biopharma speakers) from prestigious companies like Amylin Pharmaceuticals, Inc., Aptalis Pharma, Astellas Pharma, AstraZeneca, Avanir Pharmaceuticals, Bausch + Lomb, Bayer Healthcare Pharmaceuticals Inc., Boehringer Ingelheim Pharmaceuticals, CSL Behring, DARA Biosciences, Daiichi Sankyo, Inc., Dendreon, DSM Pharmaceutical, Eisai, Endo Pharmaceuticals Inc., Ipsen Biopharmaceuticals, Lupin Pharmaceuticals, Merck, NPS Pharmaceuticals, Pfizer, Regeneron Pharmaceuticals, Roche Diagnostics, Sanofi, Sanofi Pasteur, Sarepta Therapeutics, Shire Pharmaceuticals, Takeda Pharmaceutical Company, Teva, Upsher-Smith Laboratories, Vertex Pharmaceuticals, ZIOPHARM Oncology, and many more!

This prestigious event is known for providing the best and latest information to all participants. This is the premier gathering of senior level pharmaceutical, biotechnology, medical device, and diagnostics executives in competitive intelligence

“Extremely interesting conference, very relevant for CI professionals and a great opportunity to exchange ideas and challenges,” said a Sanofi Aventis participant.

“Your conference brings together the best of the Pharma CI community. I wouldn’t miss it,” enthused a Boehinger Ingelheim participant.

The 50+ sessions on all the industry’s most pressing issues are delved into in the comprehensive program agenda. Many industry insiders are calling this year’s program agenda the best agenda yet! Some topics include:
• Too Big to Succeed: Where are Large Pharmas Heading?
• Overview of Current Issues and Trends in Global Market Access and Pricing
• Crystal Ball 101: Predicting When a Competitor Drug Will Be Approved
• Competitive Intelligence: Integration, Visualization and Collaboration
• Intelligence to Insight and Decision Making How do we Move up the Data-Knowledge Pyramid?
• Challenges for CI in Rare Diseases/ Orphan Drugs
• Top 15 Pharmaceutical Companies Research
• Creating a Culture of Competitive Awareness for Pipeline vs. Approved Assets Integrating Intelligence into Operations & Strategy
• How Can Technology Streamline and Improve the Effectiveness of your Competitive Intelligence Programs?
• In the Public Eye Transparency & Access to Information
• R&D Intelligence & Its Impact on Your Company
• Moving Strategic Intelligence to an Earlier Point in the Pharmaceutical (CI) Life Cycle
• … And Much More!

More than 300 influential pharmaceutical executives attended the sold-out event last year! This is the only place for pharma decision makers to network and discuss real-world solutions. The Pharma CI Conference (pharmaciconference.com) is your EXCLUSIVE ENTRY into the world of pharmaceutical competitive intelligence. Nowhere else will you find the industry's best and brightest all under one roof!

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Pharma Market Research Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Top Pharmaceutical Experts All Coming to Groundbreaking Event in East Brunswick, New Jersey on September 17-18

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: PharmaMarketResearchConference.com 
212-228-7974 kelly[.]pharmaciconference.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Pharma Market Research Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Pharma Market Research Conference / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Celltrion Pharm Selects TrackWise QMS for Scalability and Data Integrity
Ipsen Adds Another Program into its Pre-clinical R&D Oncology Pipeline through An Exclusive Worldwide Collaboration with Accent Therapeutics
Evaxion Biotech Lauded by Frost & Sullivan for Helping Develop Highly Targeted Therapies with its AI Immunology Platforms
Kyowa Hakko Acclaimed by Frost & Sullivan for its Non-GMO, Allergen-free, Immune Support Paraprobiotic Ingredient, IMMUSE™
DSM to Acquire First Choice Ingredients to Accelerate Growth in Food and Beverage
STEMCELL Technologies Launches Human Pluripotent Stem Cell Characterization and Banking Services in Partnership with WiCell
Biocon Selects TrackWise to Enable Enterprise Quality Management Across Global Biopharmaceutical Operations
STEMCELL Technologies and Hubrecht Organoid Technology to Partner on Non-Oncology Organoid Drug Screening Services
Ipsen and Exicure Enter into Exclusive Collaboration Targeting Rare Neurodegenerative Disorders
Ipsen Strengthens its Pre-clinical Oncology Pipeline with An Exclusive Worldwide-collaboration with BAKX Therapeutics, Inc. for BKX-001
Pharma and Biotech to Highly Invest in RNA Therapeutics to Expedite Research & Development across the Globe Finds Frost & Sullivan
Parexel Commended by Frost & Sullivan for Developing a Flexible and Agile Delivery Model to Improve Clinical Trial Outcome
Ipsen and IRLAB Enter Exclusive Worldwide Licensing Agreement Aimed to Improve the Lives of People Living with Parkinson’s Disease
Exelixis and Ipsen Announce Cabozantinib in Combination with An Immune Checkpoint Inhibitor Significantly Improved Progression
Ipsen Opts-in to Join Exelixis with Ongoing Development of Cabometyx® for People Living with A Form of Thyroid Cancer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2021 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)